Janux Therapeutics (JANX) Amortizatization of Intangibles (2021 - 2025)

Janux Therapeutics (JANX) has disclosed Amortizatization of Intangibles for 5 consecutive years, with $3.5 million as the latest value for Q4 2025.

  • Quarterly Amortizatization of Intangibles rose 20.4% to $3.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $17.6 million through Dec 2025, up 66.03% year-over-year, with the annual reading at $17.6 million for FY2025, 66.03% up from the prior year.
  • Amortizatization of Intangibles for Q4 2025 was $3.5 million at Janux Therapeutics, down from $4.6 million in the prior quarter.
  • The five-year high for Amortizatization of Intangibles was $5.2 million in Q2 2025, with the low at $24000.0 in Q1 2022.
  • Average Amortizatization of Intangibles over 5 years is $2.0 million, with a median of $1.8 million recorded in 2023.
  • The sharpest move saw Amortizatization of Intangibles soared 6891.67% in 2023, then rose 6.5% in 2024.
  • Over 5 years, Amortizatization of Intangibles stood at $58000.0 in 2021, then skyrocketed by 2127.59% to $1.3 million in 2022, then surged by 59.52% to $2.1 million in 2023, then soared by 42.02% to $2.9 million in 2024, then grew by 20.4% to $3.5 million in 2025.
  • According to Business Quant data, Amortizatization of Intangibles over the past three periods came in at $3.5 million, $4.6 million, and $5.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.